Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Gotta link? Id like to save for future reference!
Im in the dark on this one!
New partnership announced with Butler Evergreen
Butler Evergreen Teams Up with Applied DNA Sciences to Ensure Highly Secure Supply Chain, Including Production, Distribution and Dispensing Locations
Wolcott-based Biopharmaceutical Company Announces Innovative Forensic Tagging Security Systems Made Possible Through Partnership with Long Island-based Biotech Firm
Wolcott, NY and Stony Brook, NY - June 15, 2015. Demonstrating its innovative and thoughtful commitment to the highest levels of security, Butler Evergreen formed an exclusive pre-application relationship with Stony Brook-based Applied DNA Sciences (NASDAQ: APDN) (Twitter: @APDN), a biotechnology firm that provides DNA-based authentication and security solutions and services. Butler Evergreen has filed a comprehensive application to become a registered organization under New York State's ("NYS") Medical Marijuana program.
"When we mapped out our security protocols for production, distribution and dispensing, we wanted to use the absolute latest technology and innovation in the security field," said Butler Evergreen CEO Scott Marshall. "As it happens, one of the leaders in this industry is another New York State-based biotechnology company, and we knew we wanted to work with them."
Based on the partnership, Applied DNA Sciences will advise and consult Butler Evergreen in developing the most secure supply chain possible, with a particular focus on protecting products during transit and at dispensary locations if Butler Evergreen's NYS application is approved.
Among other systems, Butler Evergreen intends to install Applied DNA Sciences' SigNature® DNA in its transport boxes and armored vehicles. Similar to dye packs, this DNA tagging technology will discharge a liquid dye when a transport box is illegally accessed, tagging perpetrators and products with an event-specific, traceable SigNature DNA taggant.
Similarly, Butler Evergreen intends to install Applied DNA Sciences' SmokeCloak® DNA System and Sentry Intruder Tagging System at dispensing locations. Should any security breach occur, intruders will again be tagged with a unique SigNature DNA mark. These incident-specific marks are traceable for 10 days on the subject's skin and several months on the subject's clothing and shoes. These systems will serve as a forensic tool that provides law enforcement with a means to identify offenders and any compromised products. The systems will also serve as powerful deterrent, with signage and labels letting possible offenders know that Butler Evergreen products are extremely secure.
Butler Evergreen also plans to use Applied DNA Sciences' technology to create product packaging. This will enhance seed-to-sale security, enabling the company to identify a product as authentic through unique SigNature DNA marks embedded in labels and packages.
"Working with Butler Evergreen will help to add an unprecedented level of security to this application for the state's medical marijuana program," said Applied DNA Sciences CEO James Hayward. "Our company offers security systems with unique, botanical and 'green' DNA sequences to help preserve the quality and integrity of products. In seeking out Applied DNA Sciences, Butler Evergreen is showing the world that it is taking the security of its medical products as seriously as possible."
Scott Marshall added, "Keeping our medical marijuana products safe and secure for our patients - and out of the wrong hands - is our top priority. That's what our partnership with Applied DNA Sciences will help us accomplish."
About Butler Evergreen
Butler Evergreen is focused on meeting patients' needs with state-of-the-art production of marijuana-based biopharmaceutical products. At Butler Evergreen, we will use the latest advancements in controlled-environment agriculture, biomedical processing and secure delivery systems to help New Yorkers who suffer from cancer, epilepsy, MS, ALS, Parkinson disease and other illnesses live more fruitful lives. Everything we do is for the well-being of patients.
About Applied DNA Sciences
We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the platform ingredient that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of uncopyable products such as DNAnet®, our anti-theft product, SigNature® T, targeted toward textiles, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.
Applied DNA Sciences common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.
Forward-Looking Statement
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 15, 2014, as amended on March 6, 2015 and our subsequent quarterly report on Form 10-Q filed on February 9, 2015 and May 11, 2015, which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
investor contact Debbie Bailey, 631-240-8817, debbie.bailey@adnas.com
media contact Enrique Briz, Dian Griesel Int'l, 212-825-3210, ebriz@dgicomm.com
program contacts: Michael Nizich, 631-240-8850, michael.nizich@adnas.com
Cort Ruddy, 315-427-0535, cort@pcpublicaffairs.com
web www.adnas.com
twitter @APDN
Repeat sales are based on yearly subscription for ink marks.
Then what is the point of making an actual product that companies utilize? Why not just be a stock paper mill and have nothing to show for it instead? That would be much easier than having to have 50+ employees many of which have backgrounds in DNA science.
We lost our 20 cent AH rise, but are up 17 cents on the day so far....
My right time is now! Heh. Just hard to accept that we are making more money and are less than half of where we were at split. It simply shouldn't be the way it is right now.
Why not just let it walk up? Surely that would make a lot more $$$ for all involved.
Making more money than ever, with more customers, and contracts than ever, but still with a split adjusted price of 4.4 cents. Which is absurd. When we had much fewer customers/contracts we hit 30.5 cents which todays price adjusted is over $18/share.
Why are we up 10 cents to $2.70?
Not complaining, but unusual to see a 4% rise on less than 59,000 shares traded and no news that I can see.
Thats likely due to this?
Q. BRIAN KINSTINGER - MAXIM GROUP
Great. And then on the federal piece of the business, have you been able to expand to other parts -- other than say semiconductors, and what about the expansion of federal suppliers? Have you been able to successfully expand the suppliers to the government?
A. DR JIM HAYWARD - CHAIRMAN and CEO
Well that's a very critical element, really, of both of our DoD contracts. So in particular, the contract that comes from the Office of the Secretary of Defense, has us expanding our DNA marking campaign, from a single, simple federal supply class called 5962, which is really the semiconductors to a much broader base, that totals *66 new federal supply classes. This is a lot of work to be done in the execution of that contract. And what that contract does, is build revenue for us, as we diversify the marking base.
So the answer is, yes, we are making progress, reaching out to companies that manufacture things like ball bearings, wire harnesses, wire coatings, and other industrial kinds of materials, and we are beginning those programs of DNA marking a wide variety of materials, and evaluating their performance in military circumstances.
Ooops I did it again. Bought some at $2.38, and it dropped more to $2.35. I need to quit buying.
BARRFFFF
I am tempted to buy a few more shares, however, my law will kick into effect that states any time that I buy in, it must drive the price even LOWER!
What caused todays 25 cent drop? This is insane.
Im not happy now, but patient, we are doing better, but the stock price isn't. That is what makes me unhappy. Most income ever, and we are at a price that is very close to our 8 year low. I remember presplit we had a price of .021/share for a very brief moment in time. And now, we are barely double that at .043 split adjusted.
Id like to see multiples of these pilots turn successful and go into wide commercialization.
But I fear getting to our all time split adjusted high of $18+ will take longer than 2 years.
Course of action if we hit profitability and our stock price doesn't respond...
So, a profit does not guarantee that the stock price will move in a positive direction. What would we do? What can we do? What would happen if say we break into profits and the stock doesn't do much past $5/share? I know a lot of us are underwater even at that amount in some of our positions.
Yeah this what infuriates me. The company is actually doing, selling, and generating the most cash it ever has. Compared to 4 years ago, we are in a much better position, but we are nowhere near our all time high split adjusted. Right now we are sitting at a paltry 4.285 cents/share We should be well over 20 in my opinion based on our income.
Blows me away we were at 30.5 cents when we were only making a couple hundred G's and had many fewer pilots and customers.
Last year, under a pilot study with Divatex and a major American retailer, 5 million lbs of the pima cotton harvest were SigNature T DNA-tagged. The first finished product made from this tagged fiber will be offered for sale across the US later this year under the PimaCottâ„¢ content-branded label. PimaCott is the consumer driven brand based on
SigNature T DNA marked Pima cotton. The Pimacott website was launched just last week. I would highly recommend that you take a look at it at www.pimacott.com.
Our pilot study has now transitioned to a fully commercial endeavor. APDN will enjoy revenue from 5 sources: the placement of our DNA Transfer devices at the gin, fiberTyping original fibers to ensure their authenticity before DMA marking, the supply of SigNature DNA for marking the bulk fibers, the placement of On-Site testing devices along the supply chain, and the licensing of the Pimacott brand to retailers and brandowners.
While the initial production of the first commercially available consumer goods is just nearing completion, we have already begun to receive initial orders for the coming season, and have early commitments for more than 10 million pounds of DNA-marked Pimacott for production this fall. Multiple retailers and brand-owners are being recruited.
We can see our way to $1-2 million of initial revenue after the ginning season begins, with an upside for customers who we hope will continue to sign on right through January. As global cotton is a $600 billion annual business, this represents a very large Total Addressable Market for Applied DNA and its shareholders.
Conference call video and transcript is available.
http://www.adnas.com/quarterly-results
We are at $2.59 now. Better than the $2.4 we were treading at. Still, Id much rather be at $6+ currently.
Current split adjusted price is 4.3 cents a share.
This is what infuriates me. The company, as it is, is in a much better position than any point in history, and we are still off the split adjusted price of 30.5 cents. To get there we would have to increase 26.2 cents split adjusted, or to $18.30 a share to reach that all time high.
When we were at that 30.5 cent mark, revenues were in the sub $500,000 range.
Nice numbers, revenues up, losses down. Hope we can keep this trend up and hit profitability in the next 2 years or less!
Something is up, our stock price.
Today we have shot up 23 cents share. Are we still being controlled by bigger fish to drive the share price in a desired direction for manipulation?
Nothing has been released as of late to justify such an increase such as today of 9.91%.
Wouldn't they want to be blowing their horn abit with a PR. Maybe not with a specific $$$ in the release but to say "APDN business is brisk with xyz new customers/contracts" type stuff?
Bad news that we dont know about? We are down to $2.40 a 19 cent drop today. Ugh. I just want to get back into the Mid $5s for a while.
It never fails! Bought a few more shares to average down, it goes down 4 more cents after I buy!
Good for you, Im still massively down for when I bought around $85. /sadface
Just saw this too. Unusual release though. Friday afternoon before close. And again, no info on how much they are selling these for....
When they said Euro Car maker I suspected BMW and VW, but since VW owns Porsche, good enough for me.
Remember when we hit 30.5 cents a share? That would be $18.30 cents today.
Why are we up 15 cents today?
Based on, nothing, we are up after the latest round of going down. If that last round of going down was due to the additional offering, I dont see why we would be justified in this meager increase.
Glad it is going up instead of down further, but can't make sense as to why it would without any news at all.
How so? Buy APDN after the price tanks, sell when it goes up. This has become predictable behavior. Do this, and you can no longer gripe about "employee paydays".
Sorry, that is my fault, I bought a few shares yesterday. The law as it applies to me, means that any stock I buy, MUST go down within the next 36 hours, NO MATTER WHAT.
Hard drop at the very very end, but still green for the day!
We were up for most of the day and had the standard 100 sale lots all over the place, but someone wanted out.
We dropped from 3.42 to 3.25 with a sale order of 48769 representing $158,499.25 in proceeds.
Why they sold at 3.25 instead of setting a limit at 3.42 to make $8290.73 more is a bit strange. Maybe a market order and it hit on the bid?
And down yesterday for no reason! But up the day before because of the drugs announcement. Very weird.
OK, Im going to ask that you provide proof of intentional misleading or otherwise can the crap speculation.
You are actively accusing APDN of stealing from investors. Cut this out unless you can provide reputable information that cites verifiable sources that APDN is intentionally "stealing" from investors.
We are number 8 on todays Ihub Breakoutboard!
http://investorshub.advfn.com/boards/breakoutboards.aspx
I see it as that door way we have been approaching for some time.
Things are lined up for entry into this new area of industry which, if cards played right, bode well for the company and share holders.
The fact that it meets those FDA criteria overcomes a huge hurdle already.
I had a trigger set to sell some lower priced shares I got to sell at $3.60 and we easily met that today.
Right.
This is all good stuff. Something we have been looking forward to and waiting for. My timeline of 2017 for profitability may be a bit late now if this takes off proper like. I was not expecting getting into the Pharma arena this soon.